
Ashland Inc.
NYSE•ASH
CEO: Mr. Guillermo Novo
Sector: Basic Materials
Industry: Chemicals - Specialty
Listing Date: 1980-03-17
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Contact Information
Market Cap
$2.66B
P/E (TTM)
-3.2
19.2
Dividend Yield
2.8%
52W High
$78.11
52W Low
$45.21
52W Range
Rank45Top 43.2%
4.0
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 4 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q4 2025 Data
Revenue
$478.00M-8.43%
4-Quarter Trend
EPS
$0.72+111.77%
4-Quarter Trend
FCF
$86.00M+196.55%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Personal Care Segment Strength Personal Care sales reached $577M in 2025, showing growth driven by biofunctionals and natural ingredient solutions.
Strong Liquidity Maintained Total borrowing capacity remains $596M available under Revolving Credit Facility; no maturities until fiscal 2027.
Dividend Payout Increased Quarterly cash dividend increased to $0.415 per share in May 2025, up from $0.405 previously paid.
Risk Factors
Major Goodwill Impairment Charge Recorded $706M non-cash goodwill impairment charge in Q3 2025 impacting Life Sciences and Specialty Additives units.
Significant FY Net Loss Net loss for fiscal 2025 totaled $(845)M, contrasting sharply with net income in prior fiscal years.
Trade Policy Uncertainty Risks Increased U.S. and foreign trade tariffs create macroeconomic uncertainty, straining supply chains and increasing sourcing costs.
Outlook
Fiscal 2026 Sales Guidance Expecting fiscal 2026 sales between $1.835B and $1.905B, reflecting organic growth of one to five percent.
Adjusted EBITDA Target Set Guidance targets Adjusted EBITDA for fiscal 2026 between $400M and $430M, focusing on execution.
Capital Expenditure Moderation Capital expenditures expected to average approximately $100M annually over the next three fiscal years.
Peer Comparison
Revenue (TTM)
SID$7.96B
CC$5.87B
MEOH$3.56B
Gross Margin (Latest Quarter)
WDFC54.7%
NGVT37.8%
36.6%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| AVNT | $2.83B | 25.0 | 4.8% | 32.6% |
| ASH | $2.66B | -3.2 | -37.8% | 32.1% |
| MEOH | $2.62B | 10.1 | 11.2% | 48.5% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
5.7%
Steady Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
75%
Volatile Cash Flow
Research & Insights
Reports
All Years
Form 10-K - FY 2025
Period End: Sep 30, 2025|Filed: Nov 20, 2025|Revenue: $1.82B-13.7%|EPS: $-17.87-618.0%MissForm 10-Q - Q3 2025
Period End: Jun 30, 2025|Filed: Jul 30, 2025|Revenue: $463.00M-14.9%|EPS: $-16.13-13541.7%MissForm 10-Q - Q2 2025
Period End: Mar 31, 2025|Filed: May 1, 2025|Revenue: $479.00M-16.7%|EPS: $0.68-71.9%MissForm 10-Q - Q1 2025
Period End: Dec 31, 2024|Filed: Jan 29, 2025|Revenue: $405.00M-14.4%|EPS: $-3.50-786.3%MissForm 10-K - FY 2024
Period End: Sep 30, 2024|Filed: Nov 18, 2024|Revenue: $2.11B-3.6%|EPS: $3.45+2.7%BeatForm 10-Q - Q3 2024
Period End: Jun 30, 2024|Filed: Aug 7, 2024|Revenue: $544.00M-0.4%|EPS: $0.12-85.2%MissForm 10-Q - Q2 2024
Period End: Mar 31, 2024|Filed: May 1, 2024|Revenue: $575.00M-4.6%|EPS: $2.42+43.2%BeatForm 10-Q - Q1 2024
Period End: Dec 31, 2023|Filed: Jan 31, 2024|Revenue: $473.00M-9.9%|EPS: $0.51-33.8%Beat